Hypothalamic inhibition of HIF-1α aggravates obesity-associated metabolic phenotype; this highlights the hypothalamic HIF-1α as a potential target for therapeutic intervention against obesity. This evidence concerns the gene HIF1A and obesity due to melanocortin 4 receptor deficiency.